Home › Trial NCT04951817
68Ga-PSMA PET/CT for Ra223 Assessment
- Trial IDNCT04951817
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorChang Gung Memorial Hospital
- Enrollment52
- Start date2022-03-02
- ConditionsMetastatic Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.